Viewing Study NCT05526157


Ignite Creation Date: 2025-12-24 @ 6:45 PM
Ignite Modification Date: 2026-01-05 @ 10:04 AM
Study NCT ID: NCT05526157
Status: COMPLETED
Last Update Posted: 2024-10-15
First Post: 2022-08-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module